Scientific Research

 

Drug Development Direction

In response to unmet medical needs, CaliBio specifically develops perioperative anesthesia, analgesia, anti-inflammatory and anti-infective drugs, and is committed to building a product pipeline that focuses on market segments and has global competitive advantages.

Technology platform

CaliBio has multiple patented drug delivery technology platforms. All of our patented technology platforms have significant advantages in the field of new drug R&D, especially in the field of formulation development, mainly in solving the problem of poor solubility of drug APIs, enhancing the effectiveness of drugs and slow-release capabilities.

R&D Center

CaliBio's drug R&D center focuses on the research of complex formulations. We have two R&D centers (San Diego and Shenzhen), and a clinical development center in Shanghai.